Generic Drug

Natco Pharma gains 4.5% after filing ANDA with USFDA

Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer.

Competition or legal woes? Wockhardt plunges to 1-year low

The stock has lost 36 percent in the last two weeks and 29 percent this week alone.

Why are docs raging against Aamir's generics proposal?

The reality is that apart from doctors in government hospitals, private doctors often do not suggest generic drugs because there are no kickbacks or incentives involved from pharma companies.

Cipla slashes cancer drug prices

Why Ranbaxy's gain from Lipitor deal is short-lived

Only if the company sells the generic version of Lipitor, will there be further potential in the stock, everything else is already factored in the current share price.

Govt finally gives drug R&D new life with tax reforms

On an average, Indian companies spend a mere 6% on research and development. In contrast, the figure for new drug development for global drug companies that innovate and make new drugs stands at over 13%.

Is Aamir Khan India's Bill Clinton on public health?

Aamir is perfectly right in campaigning for generic drugs. About 80 percent of our health issues can be addressed by generic versions (copies) of the original drugs that are priced several times higher.

Hamied does it again: Will Cipla’s price cut transform healthcare?

Modern cancer drugs are prohibitively expensive. By slashing prices, Yusuf Hamied is likely to change the demand-supply equation, tipping it towards large volumes and cheaper prices as in the case of AIDS-drugs.